IP Library Granted Patent US 9,192,460
Granted Patent B2
US 9,192,460 · App. 14/136,965 · Granted Nov 24, 2015

Hollow fiber ureteral stent and filter

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,192,460
App. No.
14/136,965
Granted
Nov 24, 2015
Kind
B2
Abstract

An endoluminal prosthesis for placing in a body passage of a patient, includes a ureteral stent, the ureteral stent comprising a generally tubular housing having a proximal end and a distal end and a lumen longitudinally disposed therethrough, at least one hollow fiber tubule disposed within the tubular housing, and at least one anchoring mechanism disposed on a distal end of the tubular housing.

Claims (34)

1. An endoluminal prosthesis for placing in a body passage of a patient comprising

a ureteral stent, the ureteral stent comprising a generally tubular housing having a proximal end and a distal end and a lumen longitudinally disposed therethrough,

at least one hollow fiber tubule disposed within the tubular housing, the at least one hollow fiber tubule comprising an external membrane layer, and internal membrane layer, and a lumen; and

at least one anchoring mechanism disposed on the tubular housing,

wherein the at least one hollow fiber tubule is configured to filter bacteria and salt crystals from urine.

2. The endoluminal prosthesis of claim 1 , wherein the generally tubular housing is porous.

3. The endoluminal prosthesis of claim 2 , wherein the pores of the generally tubular housing range from about 1 cm 2 to 5 cm 2 .

4. The endoluminal prosthesis of claim 1 , wherein the external membrane layer is microporous or nanoporous.

5. The endoluminal prosthesis of claim 1 , wherein the internal membrane layer is macroporous.

6. The endoluminal prosthesis of claim 1 , wherein the external membrane layer and the internal membrane layer are negatively charged.

7. The endoluminal prosthesis of claim 1 , wherein a pharmaceutically active carrier is disposed on outer surface of the at least one hollow fiber tubule.

8. The endoluminal prosthesis of claim 1 , wherein a pharmaceutically active carrier is disposed on an outer surface and an inner surface of the generally tubular housing.

9. The endoluminal prosthesis of claim 1 , wherein the at least one anchoring member comprises a generally hemispherical sleeve.

10. The endoluminal prosthesis of claim 1 , wherein the at least one anchoring member further includes a magnet, the magnet configured to engage with a corresponding magnet of an introduction assembly.

11. The endoluminal prosthesis of claim 1 , further comprising an outlet disposed proximal of the at least one hollow fiber tubule.

12. The endoluminal prosthesis of claim 1 , further comprising an inner tube disposed through the lumen of the tubular housing.

13. An endoluminal prosthesis for placing in a body passage of a patient comprising,

a ureteral stent having a proximal end and a distal end and a lumen longitudinally disposed therethrough, the ureteral stent comprising at least one hollow fiber having an external membrane and an internal membrane; and

at least one anchoring mechanism disposed on the ureteral stent,

wherein the hollow fiber tubule is configured to filter bacteria and salt crystals from urine.

14. The endoluminal prosthesis of claim 13 , wherein the external membrane layer is microporous or nanoporous and the internal membrane layer is macroporous.

15. The endoluminal prosthesis of claim 13 , wherein the external membrane layer and the internal membrane layer are negatively charged.

16. The endoluminal prosthesis of claim 13 , wherein the at least one anchoring member comprises a generally hemispherical sleeve.

17. The endoluminal prosthesis of claim 13 , wherein the at least one anchoring member further includes a magnet.

18. The endoluminal prosthesis of claim 13 , wherein a pharmaceutically active carrier is disposed on outer surface of the hollow fiber tubule.

19. The endoluminal prosthesis of claim 13 , further comprising an inner tube disposed through the lumen of the tubular housing.

20. A kit for placing an endoluminal prosthesis comprising,

a ureteral stent, the ureteral stent comprising

a generally tubular housing having a proximal end and a distal end and a lumen longitudinally disposed therethrough,

at least one hollow fiber tubule disposed within the tubular housing, and

at least one anchoring mechanism disposed on the tubular housing;

an introduction assembly, the introduction assembly comprising a wire shaft having a proximal end and a distal end and a first magnet connected to the distal end of the wire shaft; and

an access sheath surrounding the ureteral stent and the introduction assembly;

where the first magnet is configured to engage with a corresponding magnet on at least one anchoring mechanism.

Assignments (3)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2014
From: GANDHI, NEENA
To: COOK INCORPORATED
Reel/Frame 031940/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2014
From: COOK INCORPORATED
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 031940/0863 →